Last update 21 Nov 2024
CKD-702
Last update 21 Nov 2024
Overview
Basic Info
Drug Type Bispecific antibody |
Synonyms |
Target |
Mechanism EGFR antagonists(Epidermal growth factor receptor erbB1 antagonists), c-Met inhibitors(Hepatocyte growth factor receptor inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
3
Clinical Trials associated with CKD-702Phase 1b/2 trial for CKD-702 in combination with irinotecan as a third-line therapy for gastric cancer with MET or EGFR protein overexpression
CKD-702 Plus Irinotecan as a ≥3L Therapy for Gastric and Gastroesophageal Junction Adenocarcinomas Overexpressing EGFR or MET
A Multicenter, Open-Label, Dose-Escalation and Dose-Expansion, Phase I Study to Evaluate the Safety, Pharmacokinetics and Anti-tumor Effects of CKD-702 in Patients With Advanced or Metastatic Non-small Cell Lung Cancer Who Failed to Standard Therapy
100 Clinical Results associated with CKD-702
Login to view more data
100 Translational Medicine associated with CKD-702
Login to view more data
100 Patents (Medical) associated with CKD-702
Login to view more data
100 Deals associated with CKD-702
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Gastroesophageal junction adenocarcinoma | Phase 2 | KR | 01 Dec 2022 | |
| metastatic non-small cell lung cancer | Phase 1 | KR | 21 May 2020 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
NCT04667975 (ESMO2022) Manual  | Phase 1 | metastatic non-small cell lung cancer EGFR Exon 19 Deletion | EGFR L858R | Met Exon 14 Skipping ... View more | 24 | (All pts) | (atoadykeau) = uzyxvmbetx yqkttcnatp (yukhcoegag ) View more | Positive | 10 Sep 2022 |
(Met ex14 skipping) | (vbxwisxfkm) = ivpnrpqqzz gocenfkzwa (myyekwumfu ) View more |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free